MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2022 International Congress

    Worse Sleep Quality Aggravates the Motor and Non-Motor Symptoms in Parkinson’s Disease

    Y. Qu, YP. Chen, L. Li, JY. Li, QX. Qin, DL. Wang, JW. Zhao, ZJ. Mao, YJ. Xiong, Z. Min, Z. Xue (Wuhan, China)

    Objective: The current study aims to investigate the association of sleep characteristics with motor and non-motor dysfunctions of Parkinson’s disease (PD) in a single-center, observational,…
  • 2022 International Congress

    Parkinsonian disorders may have different pain features.

    SY. Kang, YH. Sung (Hwaseong, Republic of Korea)

    Objective: The aim of this study was whether the pain is a unique feature of Parkinson's disease, which precedes motor symptoms, and its characteristics would…
  • 2022 International Congress

    ASYMMETRIC EARLY-ONSET PARKINSONISM DUE TO PSEN1 MUTATION

    E. Luque-Buzo, J. Pérez Sáchez, M. Gonzalez-Sanchez, A. Contreras-Chicote, S. Secades, B. Casa-Fages, F. Grandas (Madrid, Spain)

    Objective: To report a novel case of early-onset parkinsonism due to a presenilin 1 gene (PSEN1) mutation. Background: Mutations in PSEN1 gene are the most…
  • 2022 International Congress

    Development of C-terminal α-Synuclein Vaccine for Treatment and Prevention of Parkinson’s Disease and Other Synucleinopathies

    R. Barbour, A. Elmaarouf, L. Louie, S. Tam, C. Tourino, B. Campbell, G. Kinney, W. Zago (South San Francisco, USA)

    Objective: Prothena is developing active vaccine candidates targeting α-synuclein (α-syn) epitopes shown in clinical and/or preclinical studies to disrupt synuclein pathology. These vaccines, which target…
  • 2022 International Congress

    Assessment of cognitive functions and gait in PD and ET patients with pharmacoresistant tremor treated with Gamma Knife thalamotomy.

    M. Figura, L. Milanowski, K. Sadowski, A. Korn, A. Ziobro, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of our study was to assess the impact of unilateral Gamma Knife thalamotomy on gait and balance and well as psychological functioning…
  • 2022 International Congress

    Alpha-synuclein fibril-based mouse model of REM sleep behavior disorder as a prodrome of synucleinopathy

    HS. Yoo, R. Luke, C. Durso, Y. Liang, J. Steltz, D. Chernoff, B. Zhang, KH. Hoxha, B. Dugan, JJ. Fraigne, W. O’Brien, J. Peever, K. Luk (Seoul, Republic of Korea)

    Objective: To investigate whether in wild-type mice, inoculation of α-synuclein (aSyn) preformed fibrils (PFFs) into the sublaterodorsal tegmental nucleus (SLD), a core structure associated with…
  • 2022 International Congress

    Safinamide as an adjunct to Levodopa Therapy in Asian and Caucasian Patients with Parkinson’s Disease and Motor Fluctuations: A post-hoc Analysis of the SETTLE study

    R. Bhidayasiri, T. Ishida, RE. Husni, T. Kamei, I. Suzuki, SL. Wu, JW. Cho (Bangkok, Thailand)

    Objective: This study evaluated the efficacy and safety outcomes of safinamide as a levodopa adjunct therapy in Asian and Caucasian patients with Parkinson’s disease. Background:…
  • 2022 International Congress

    A secretory vesicle failure in Parkinson’s disease occurs in human platelets

    P. Montenegro, M. Pueyo, JN. Lorenzo, R. González-Brito, A. Méndez, R. Borges (La Laguna, Spain)

    Objective: Since platelets use similar, if not the same, mechanisms to accumulate serotonin (5-HT) as dopaminergic neurons to store DA in their VS; we wonder…
  • 2022 International Congress

    Vascular Causes of Atypical Parkinsonism Versus Vascular Contribution Towards Atypical Parkinsonism

    M K. Acharya (KHARAGPUR, India)

    Objective: In this study, we have compared the clinical features of atypical parkinsonism with high vascular load to find the difference between isolated vascular pathology…
  • 2022 International Congress

    CLINICAL AND GENEOLOGICAL FEATURES OF PARKINSON’S DISEASE

    S. Kuranbaeva, S. Kalandarova, A. Umarov, G. Goyibova (Tashkent, Uzbekistan)

    Objective: The initial purpose of the work is to study the clinical and genealogical features of Parkinson's disease. Background: Currently, clinical genetics has a number…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley